本頁面由Tiger Trade Technology Pte. Ltd.提供服務

神經分泌生物科學

150.73
+1.230.82%
成交量:10.72萬
成交額:1,615.27萬
市值:153.74億
市盈率:22.09
高:151.83
開:151.14
低:150.00
收:149.50
52周最高:186.12
52周最低:122.14
股本:1.02億
流通股本:9,999.56萬
量比:0.57
換手率:0.11%
股息:- -
股息率:- -
每股收益(TTM):6.82
每股收益(LYR):4.67
淨資產收益率:22.09%
總資產收益率:11.70%
市淨率:4.16
市盈率(LYR):32.28

資料載入中...

2025/10/28

重要事件披露

Form 8-K - Current report
2025/08/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/07/30

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/07/30

重要事件披露

Form 8-K - Current report
2025/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/07/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/30

重要事件披露

Form 8-K - Current report
2025/05/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/22

重要事件披露

Form 8-K - Current report
2025/05/21

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/05/21

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/05/21

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/05/21

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/05/21

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/05/21

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/05/21

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/05/21

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/05/21

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/05/21

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/05/21

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans